You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of Real-Time Flare Combustion Efficiency Monitor

    SBC: Providence Photonics, LLC            Topic: E

    There are approximately 7,000 flares in operation at industrial facilities across the U.S. Flares are one of the largest Volatile Organic Compounds (VOC) and air toxics emissions sources. Based on a special emission inventory required by the Texas Commission on Environmental Quality in 2007, highly reactive VOC emissions from 28 flares located in 11 facilities in Harris County, Texas, where 1,46 ...

    SBIR Phase I 2013 Environmental Protection Agency
  2. Immunoassay for diagnosis of invasive fungal disease

    SBC: TUMOREND, LLC            Topic: NIGMS

    DESCRIPTION: We have preliminary data for a small molecule glyco-decoy that specifically side-tracks the biosynthesis of the ligand for E-selection, and is a candidate for a novel anti-inflammatory. The three members E, L and P of the selection family areinflammatory adhesion molecules expressed constitutively on the surface of blood leukocytes and on activated endothelial cells and platelets. Dis ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica

    SBC: DEKK-TEC INC            Topic: NCI

    DESCRIPTION (provided by applicant): The principal goal of this research project will be to evaluate 4-demethyl-4- cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN), a polychlorinated cholesterol carbonate as anticancer therapy for patients with advanced cancer in a Phase II clinical trial. During pre-clinical studies DM-CHOC-PEN produced complete remissions with long term survival vs. intracranial ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government